Syntax Research’s Amgen AMGN Stock Holding History

Syntax Research’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$85.8K	Hold	237	–	–	0.06%	79
2026 Q1	$83.4K	Hold	237	–	–	0.05%	84
2025 Q4	$77.6K	Hold	237	–	–	0.05%	85
2025 Q3	$66.9K	Hold	237	–	–	0.04%	85
2025 Q2	$66.2K	Hold	237	–	–	0.05%	79
2025 Q1	$73.8K	Hold	237	–	–	0.05%	82
2024 Q4	$61.8K	Hold	237	–	–	0.04%	83
2024 Q3	$76.4K	Hold	237	–	–	0.05%	77
2024 Q2	$74.1K	Hold	237	–	–	0.06%	69
2024 Q1	$67.4K	Hold	237	–	–	0.05%	77
2023 Q4	$68.3K	Hold	237	–	–	0.06%	74
2023 Q3	$63.7K	Buy	+237	New	+$59.1K	0.05%	82

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Syntax Research's AMGN Position: Q2 2026 in Review

Syntax Research held its Amgen (AMGN) position steady in Q2 2026 at 237 shares worth $85.8K. The position accounts for 0.06% of the portfolio, ranked #79.

Syntax Research first reported a position in AMGN in Q3 2023 and has held it in 12 quarters since. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Syntax Research held 237 shares of Amgen worth $85.8K as of Q2 2026.
Syntax Research left its Amgen share count unchanged in Q2 2026.
Amgen made up 0.06% of Syntax Research's portfolio in Q2 2026, its #79 holding.
Syntax Research first reported a position in Amgen in Q3 2023 and has held it in 12 quarters since.
3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Syntax Research's 13F filing for Q2 2026, filed 31 Jul 2026.